Elagolic Tablet 200 mg contains Elagolix Sodium, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used in the management of endometriosis-associated pain. It works by reducing estrogen production in a dose-dependent manner, helping to control symptoms such as pelvic pain, painful menstruation, and discomfort associated with endometrial tissue growth.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
Each tablet contains:
This higher-strength formulation provides more pronounced hormonal suppression under medical supervision.
Indications
Elagolic Tablet is indicated for:
-
Endometriosis-associated moderate to severe pain
-
Dysmenorrhea related to endometriosis
-
Chronic pelvic pain due to endometrial lesions
-
Hormone-dependent gynecological pain conditions
It is prescribed for women of reproductive age under specialist guidance.
Pharmacological Action
Elagolix acts by modulating the hypothalamic-pituitary-ovarian axis:
-
Blocks GnRH receptors in the pituitary gland
-
Suppresses release of LH and FSH hormones
-
Reduces ovarian estrogen production
-
Lower estrogen levels decrease endometrial tissue activity and inflammation
This leads to a reduction in pain and other endometriosis-related symptoms.
Dosage & Administration
-
Usual dose: 200 mg twice daily or as directed by the physician
-
Can be taken with or without food
-
Should be taken at the same time each day
-
Treatment duration is limited and should be closely monitored by a healthcare professional
Do not adjust dosage without medical advice.
Side Effects
Common side effects may include:
-
Hot flashes
-
Headache
-
Nausea
-
Mood changes or irritability
-
Irregular menstrual bleeding
-
Decreased bone mineral density with prolonged use
Report any severe mood disturbances or persistent symptoms to a healthcare provider.
Contraindications
-
Pregnancy (strictly contraindicated)
-
Known hypersensitivity to Elagolix or any component
-
Severe hepatic impairment
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Precautions & Warnings
-
May reduce bone density with long-term use
-
Non-hormonal contraception is recommended during treatment
-
Monitor for mood changes, depression, or suicidal thoughts
-
Use with caution in liver impairment
-
Therapy duration should be limited as prescribed
Use in Pregnancy & Lactation
Elagolix is contraindicated during pregnancy and should not be used in breastfeeding women. Effective contraception is required throughout treatment.
Storage
-
Store below 30°C
-
Keep in a dry place, away from light and moisture
-
Keep out of reach of children.